protein-based hepatitis B vaccine (Transgene Biotek)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameprotein-based hepatitis B vaccine (Transgene Biotek)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTransgene Biotek Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransgene Biotek Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A